Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 46Squamous Cell Carcinoma of Head and Neck 23Lung Neoplasms 22Oropharyngeal Neoplasms 13Urinary Bladder Neoplasms 12Nasopharyngeal Carcinoma 12Carcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 8Biliary Tract Neoplasms 8Uterine Cervical Neoplasms 7Head and Neck Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Esophageal Squamous Cell Carcinoma 6Colorectal Neoplasms 6Cholangiocarcinoma 6Small Cell Lung Carcinoma 5Neoplasm Metastasis 5Mouth Neoplasms 5Endometrial Neoplasms 5Stomach Neoplasms 4Laryngeal Neoplasms 4Esophageal Neoplasms 4Carcinoma, Squamous Cell 4Ovarian Neoplasms 3Neoplasms by Site 3Mesothelioma, Malignant 3Lymphoid Interstitial Pneumonia 3Hypopharyngeal Neoplasms 3Carcinoma, Transitional Cell 3

Interventions

Radiotherapy, Conformal 2Radiotherapy 2Paclitaxel 2Carboplatin 2veliparib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Nivolumab 1Metformin 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Docetaxel 1Disulfides 1Cisplatin 1CTLA-4 Antigen 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Bronchiolo-Alveolar × Cisplatin × 30 days × Clear all
NCT00334815 2026-05-26

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2 Active not recruiting
29 enrolled 10 charts
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡